Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers (Part 1)”

328 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 328 results

Early research (Phase 1)Study completedNCT02321644
What this trial is testing

Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study

Who this might be right for
Healthy Subjects
Celgene Corporation 26
Testing effectiveness (Phase 2)Study completedNCT01413932
What this trial is testing

Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

Who this might be right for
Healthy Volunteers (Part 1)Major Depressive Disorder (Part 2)
Dart NeuroScience, LLC 26
Early research (Phase 1)Not Yet RecruitingNCT07314346
What this trial is testing

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Who this might be right for
Healthy Volunteer Study
Atea Pharmaceuticals, Inc. 32
Early research (Phase 1)Study completedNCT03340220
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.

Who this might be right for
Healthy Volunteers
Xenon Pharmaceuticals Inc. 130
Early research (Phase 1)Study completedNCT04008186
What this trial is testing

A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

Who this might be right for
Healthy Adult Subjects
Biogen 61
Early research (Phase 1)Study completedNCT03108274
What this trial is testing

A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 35
Early research (Phase 1)Study completedNCT05684289
What this trial is testing

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 61
Early research (Phase 1)Study completedNCT03395249
What this trial is testing

Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994

Who this might be right for
Healthy Volunteers
Spero Therapeutics 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT02629692
What this trial is testing

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Who this might be right for
Healthy (For Part A)Chronic Myeloid Leukemia (for Part B and C)
Sun Pharma Advanced Research Company Limited 122
Early research (Phase 1)Study completedNCT05994963
What this trial is testing

Compare Different Preparations of Sisunatovir in Healthy Adult Participants.

Who this might be right for
Healthy
Pfizer 25
Early research (Phase 1)Looking for participantsNCT07063342
What this trial is testing

Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 72
Early research (Phase 1)Study completedNCT03154086
What this trial is testing

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

Who this might be right for
Irritable Bowel Syndrome
GlaxoSmithKline 68
Early research (Phase 1)Study completedNCT05981365
What this trial is testing

Voxelotor CYP and Transporter Cocktail Interaction Study

Who this might be right for
Sickle Cell Disease
Pfizer 44
Early research (Phase 1)Study completedNCT03174041
What this trial is testing

A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin

Who this might be right for
Healthy Participants
Genentech, Inc. 63
Early research (Phase 1)Study completedNCT05797753
What this trial is testing

Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)

Who this might be right for
Amyotrophic Lateral SclerosisHealthy Volunteer
Sanofi 16
Early research (Phase 1)Ended earlyNCT05629741
What this trial is testing

A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101

Who this might be right for
Community-acquired PneumoniaBacterial Pneumonia
Clarametyx Biosciences, Inc. 28
Testing effectiveness (Phase 2)Ended earlyNCT03866577
What this trial is testing

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Momenta Pharmaceuticals, Inc. 50
Early research (Phase 1)Study completedNCT05644977
What this trial is testing

A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

Who this might be right for
Healthy ParticipantsAlzheimer's Disease Dementia
AbbVie 17
Early research (Phase 1)Ended earlyNCT04485663
What this trial is testing

ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Who this might be right for
Chronic Hepatitis B
Aligos Therapeutics 103
Early research (Phase 1)Study completedNCT05780645
What this trial is testing

Investigate the Pharmacokinetic Profile of ALXN2050 Modified Release Prototype Formulations and Immediate Release Reference Tablet in Healthy Adult Participants

Who this might be right for
Healthy Participants
Alexion Pharmaceuticals, Inc. 80
Load More Results